(*contributed equally to this work) 发布: 2017年06月20日第7卷第12期 DOI: 10.21769/BioProtoc.2350 浏览次数: 8661
评审: Yanjie LiLeonardo G. GuilgurAnonymous reviewer(s)
Abstract
Genomic sequencing efforts can implicate large numbers of genes and de novo mutations as potential disease risk factors. A high throughput in vivo model system to validate candidate gene association with pathology is therefore useful. We present such a system employing Drosophila to validate candidate congenital heart disease (CHD) genes. The protocols exploit comprehensive libraries of UAS-GeneX-RNAi fly strains that when crossed into a 4XHand-Gal4 genetic background afford highly efficient cardiac-specific knockdown of endogenous fly orthologs of human genes. A panel of quantitative assays evaluates phenotypic severity across multiple cardiac parameters. These include developmental lethality, larva and adult heart morphology, and adult longevity. These protocols were recently used to evaluate more than 100 candidate CHD genes implicated by patient whole-exome sequencing (Zhu et al., 2017).
Keywords: Drosophila (果蝇)Background
The use of the Drosophila model to elucidate molecular mechanisms underlying human diseases is well documented (Bier and Bodmer, 2004; Cagan, 2011; Zhang et al., 2013; Owusu-Ansah and Perrimon, 2014; Diop and Bodmer, 2015; Na et al., 2015), and 75% of human disease associated genes are represented by functional homologs in the fly genome (Reiter et al., 2001). While it is a challenge to link Drosophila developmental phenotypes directly to patient symptoms, Drosophila can be used as a very sophisticated and efficient platform to test and validate candidate disease gene function in development, and this can readily be scaled to evaluate a large number of candidate genes identified from patient genomic sequencing efforts. Drosophila has been used to study genes related to CHD for over 20 years, based on evolutionarily conserved genetic mechanisms of heart development (Bier and Bodmer, 2004; Olson, 2006; Yi et al., 2006). We developed a highly efficient cardiac-targeted gene silencing approach in flies to examine effects on heart structure and function for fly homologs of candidate CHD genes (Zhu et al., 2017).
Materials and Reagents
Equipment
Software
Procedure
Data analysis
Notes
Acknowledgments
Z.H. was supported by grants from the National Institutes of Health (RO1-HL090801, RO1-NK098410).
References
文章信息
版权信息
Zhu et al. This article is distributed under the terms of the Creative Commons Attribution License (CC BY 4.0).
如何引用
Readers should cite both the Bio-protocol article and the original research article where this protocol was used:
分类
发育生物学 > 细胞生长和命运决定 > 成熟衰老
系统生物学 > 基因组学 > 功能基因组学
您对这篇实验方法有问题吗?
在此处发布您的问题,我们将邀请本文作者来回答。同时,我们会将您的问题发布到Bio-protocol Exchange,以便寻求社区成员的帮助。
提问指南
+ 问题描述
写下详细的问题描述,包括所有有助于他人回答您问题的信息(例如实验过程、条件和相关图像等)。
Share
Bluesky
X
Copy link